KRAS mutation identified in a patient with melorheostosis and extended lymphangiomatosis treated with sirolimus and trametinib.
Clara Lacasta-PlasinVictor Martínez-GonzálezLara Rodriguez-LagunaAntonio Cervantes-PardoTeresa Martinez-MenchonRegina Sanchez-JimenezMinia Campos-DominguezPublished in: Clinical genetics (2021)
Detection of KRAS mutation in skin biopsy in a patient with melorheostosis, lymphantiomatosis and vascular stenosis. She was successfully treated with trametinib.